Ad

CGS – CogState Ltd

🔒

Subscribe for full access

Unlock Industry-grade Shariah Compliance for US, UK, Canada, Germany, GCC, Europe and India. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.

Get started from just $1/month

Ad

Recommendation Rating

2

1

2

3

4

5

1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Analysts’ Price Targets

Mean 1.27

Low: 0.94

High: 1.55

Total Analysts: 4

Company Profile

Cogstate Ltd is an Australia-based neuroscience technology company. The Company optimizes brain health assessments to develop new medicines and to enable earlier clinical insights in healthcare. The Company’s technologies provide computerized cognitive tests across a list of domains and support electronic clinical outcome assessment (eCOA) solutions. The Company operates through two segments: Clinical Trials and Healthcare. Its Clinical Trials segment’s solutions guide various researchers across many indications and all phases of development. It helps clinical trial partners to optimize outcomes with the help of its computerized cognitive tests, rater training and data quality programs, and study design insights from scientists. Its Healthcare segment provides tools to screen and monitor cognitive changes in the clinical and community settings.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan

Ad

Responses